FDA Joining NIH To Discuss Therapeutic Potential Of Cannabinoids

By Beth Wang
December 3, 2018 at 6:08 PM
FDA will join representatives from the National Institutes of Health (NIH), the Drug Enforcement Administration, academia and industry to discuss the regulatory landscape and future research opportunities of cannabinoids during a Dec. 8 workshop, NIH announced on the Federal Register Monday (Dec. 3). The goal of the meeting, according to NIH’s agenda, is to: gain an understanding of how to navigate the regulatory space; inform the research and regulatory community of the National Center for Complementary and Integrative Health...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on the coming Democrat-controlled House of Representatives, drug pricing reforms, Medicaid policy, FDA news and much more.